Institute Archive 2017-2018

iStock-464615957.jpg

Scroll Down for Details and Links
Throughout the year we gather researchers, engineers and data scientists to share knowledge, best practices, and find fresh collaborations.

Already, new initiatives are developing, spurred by the exchange of ideas and challenges that are shared through these programs.

Want to know more? Get In Touch!

Click for a Simple List of All Past Recordings



Rare Disease Research Hub

Rare Disease Update: Repurposing Drugs Through Computational Biology
Bruce Bloom, DDS, JD, CEO, Cures Within Reach
More Information • RecordingPDF

Exciting therapeutic potential in the repurposing of approved drugs is becoming a reality. Nowhere else does this practice have as much of a potential impact than in the treatment of rare diseases. Dr. Bloom discusses the benefits and challenges of drug repurposing, providing historical and contemporary successes with a focus on rare diseases.

Building the Rare Disease Research Community
Wendy Chung, MD, Ph.D., Kennedy Family Professor of Pediatrics and Medicine
Columbia University
More Information • RecordingPDF

Dr. Chung gives insights into her extensive work identifying new genes linked to rare diseases along with forefront approaches and challenges in the field. She discusses the rise and application of precision medicine techniques, generation of new data and research models, and the potential for genome-based targeting in advanced treatments.

Lab to Market

inventor-entrepreneur.jpeg

Are You an Inventor, or Are You an Entrepreneur? 
Russell Thomas, Co-Founder and CEO, NIRvana Sciences
More Information • RecordingPDF

Starting a new life science company is not for the faint of heart. In this presentation, we explore the dimensions of personality and energies that are expressed in the lab and as the driver of business. Without judgement, we ask you to consider the anticipated journeys that can help you determine your approach to commercializing your breakthroughs.

Shaping Drug Development Programs around Commercial Elements
Roland Turck, MD, Managing Partner, TurckBio
More Information • RecordingPDF

Dr. Turck will detail ways to incorporate commercial strategy into every stage of a life science product's development. He will discuss the market-to-product thought process required for a company and its intellectual property to realize their full potential. 


Bench to Bedside: Taking Research to the Market
Vinit Nijhawan, Managing Director, University Patent Monetization Program
UnitedLex and its subsidiary iRunway
More Information • RecordingPDF

Prior to UnitedLex Vinit was Managing Director, Office of Technology Development at Boston University where he launched 8 venture-backed spinoffs and successfully executed a patent monetization program.

Emerging Technologies and Innovation

Building the Biotech Cluster, Innovation Cluster Development in a Dynamic Environment
Steve Wray, VP and Director, Regional Economics and Labor, Econsult Solutions
More Information • RecordingPDF

Cluster building is a multi-tiered, multi-year initiative, requiring the combined resources and collaborative efforts of numerous individuals and organizations. However, the resulting supportive life science infrastructure lays an enduring foundation for the future. In alignment with our mission, we look to other clusters for lessons learned during times of directed growth.

Practical Implications for AI and Machine Learning
Brian Hand, Partner, Nordlicht & Hand
More InformationRecordingPDF

Growth in the use of artificial intelligence and machine learning by life science companies and researchers will revolutionize the field of biotechnology. This webinar will examine the growth in the use of artificial intelligence, its impact on innovation as we move forward.

researchers4.jpg

Emerging Technologies: Synthetic Biology, A Revolution Across All Industries
Karl Schmieder, CEO, messagingLAB
More InformationRecordingPDF

In this webinar we discuss the difference between biotechnology and synthetic biology, explore the impact synthetic biology is already having on business, and highlight how synthetic biology is evolving in New York State.

data science 2.jpeg

Translating Data Science, Addressing Interoperability
Hareesh Chandrupatla, Chief Data Scientist, Anjin Analytics
Angela Radcliffe, General Manager, Clinical Trial Solutions, PulsePoint
Kyle Gallatin, Data Scientist, Pfizer
Jabe Wilson, Consulting Director, Text and Data Analytics, Reed ElSevier
More InformationRecordingPDF

Often, incompatibility between data sets leads to challenges in the analysis and useful interpretation of information. Add in the complexity of HIPAA, and it’s an all-hands-on-deck moment for data scientists managing ever growing amounts of data.

Intellectual Property

IP_Roundtable.jpeg

Intellectual Property: Timing is Everything 
Scott D. Locke, Esq., Partner & Chair, Intellectual Property Department, Dorf & Nelson
More Information • RecordingPDF

When it comes to developing a patent protection strategy there are many issues to consider. One of the most critical of these issues is determining when, during the innovation process, the right time to file for patent protection is. Expert advice in identifying that time is crucial to realizing your full market potential.

Government Relations

edited.jpg

Government Relations Midterm Update, Outlook for 2019
Lisa Wickens-Alteri, President, Capital Health Consulting
Matthew McLarnon, Government Relations and Policy Associate, Capital Health Consulting
Andrew Zebrak, Executive Director, Public Policy and Advocacy, Boehringer Ingelheim
More Information • RecordingPDF

After the midterms, what changes in policy may be on the horizon and how will we best navigate them? Experts from our Advisory Board will update us on state and federal life science policy moving forward, anticipating challenges to prepare for and identifying opportunities to support.

govt relations.jpeg

Making a Difference Through Smart Government Relations
Lisa Wickens-Alteri, President, Capital Health Consulting
Matthew McLarnon, Government Relations and Policy Associate, Capital Health Consulting
More Information • RecordingPDF

Over 47 companies have launched in New York State over the last three decades, placing NY in the #2 spot in the nation for funding biotech and life science research and development. Even with the positive influx of investment and the establishment of science as a public authority in New York, the industry is still confronted by governmental barriers and bureaucratic policy.

ESD webinar.jpeg

Incentives for New York State Life Science Companies
Loretta Beine, Life Science Industry Development Director, Empire State Development (ESD)
More Information • RecordingPDF

Life Science companies, along with their suppliers and partners, can benefit from a range of New York state incentives, including a new R&D tax credit progam. These programs encourage business investment and job creation, supporting diverse, prosperous local economies across New York State.

Sustainability

Leveraging Sustainability to Save Your Lab Budget
Erika Daley, Program Manager, My Green Lab
Stephen Harris, Ph.D., Assistant Professor of Biology, Purchase College, SUNY
More InformationRecordingPDF

Through the smart use of energy, water, reagents, and more, your lab can become more sustainable while simultaneously reducing operational costs. Practical steps to operate more sustainably in your lab right now are presented.

Communicating Biomedical Research

pexels-photo-935977.jpeg

Rigor and Reproducibility: Presenting Data to Funders and Investors
Rick Huntress, Director Business Development, Clinical/In Vivo Services, The Jackson Laboratory
More Information • RecordingPDF

Criteria that investors and companies use to evaluate drugs for licensing or acquisition can be different from those used by reviewers and journals for publication. In this webinar, we will discuss strategies that allow researchers to anticipate such concerns and generate the kind of data that investors appreciate.

Spark Talks.jpg

Nailing Your Spark Talk
Laura Green, Ph.D., Cancer Consortium Manager, Fred Hutchinson Cancer Research Center
More Information • RecordingPDF

Do you have a short, 1-3 minute talk to prepare?  Is your topic complex and seemingly hard to condense? Dipping your toes into the world of spark talks can be daunting without prior experience. This session aims to help early-career technologists prepare and plan for this popular form of science communication.

LauraGreen2.jpg

Science Communication: General Concepts and Tips
Laura Green, Ph.D., Cancer Consortium Manager, Fred Hutchinson Cancer Research Center
More Information • RecordingPDF

This session covers key practical approaches to considering your presentation audience, telling a compelling story of your research, effectively addressing questions, and developing powerful presentations to engage your audience.


Peer-to-Peer Communication
 
Laura Green, Ph.D., Cancer Consortium Manager, Fred Hutchinson Cancer Research Center
More Information • RecordingPDF

This session focuses upon effective communication with other scientists in symposia, lab meetings, seminars, and thesis defenses. Included are guidelines for effective presentations, slide preparation, and meaningful interaction with your audience.